CureVac N.V. Equity-NMS: CVAC

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Error in Fetching Data, Please retry later.
Previous close :$2.86
Open :$2.83
Today's high :$2.9
Today's low :$2.78
52W low :$2.215
52W high :$5.28
EPS(TTM): :0.51
Shares O/S :224.34 M
Market cap :637.12 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
CureVac N.V. $2.84 0% 5.61 637.12M

Frequently Asked Questions

What is the share price of CureVac N.V. today?

CureVac N.V. (CVAC) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About CureVac N.V.

CureVac NV, formerly CureVac AG, is a Germany-based clinical-stage biopharmaceutical company. The Company develops transformative medicines based on messenger ribonucleic acid, or mRNA. The Company's mRNAs are designed to prevent infections and to treat diseases by mimicking human biology to synthesize the desired proteins. Its technology platform optimizes mRNA constructs that encode functional proteins which either induce a desired immune response or replace defective or missing proteins using the cell’s intrinsic translation machinery. The Company's product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and molecular therapy. In prophylactic vaccines, the Company is advancing its second-generation mRNA backbone against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and a range of infectious diseases, including seasonal influenza, in collaboration with GSK(Glaxo Smith Kline).